Difference between revisions of "Template:Ionotropic glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Medgirl131
imported>Medgirl131
 
(20 intermediate revisions by 7 users not shown)
Line 3: Line 3:
 
  | title = [[Ionotropic glutamate receptor]] [[receptor modulator|modulator]]s
 
  | title = [[Ionotropic glutamate receptor]] [[receptor modulator|modulator]]s
 
  | state = {{{state<includeonly>|collapsed</includeonly>}}}
 
  | state = {{{state<includeonly>|collapsed</includeonly>}}}
  | listclass = hlist
+
  | bodyclass = hlist
 
  | groupstyle = text-align:center;
 
  | groupstyle = text-align:center;
  
Line 18: Line 18:
 
* [[Quisqualic acid]]
 
* [[Quisqualic acid]]
 
* [[Willardiine]]; ''Positive allosteric modulators:'' [[Aniracetam]]
 
* [[Willardiine]]; ''Positive allosteric modulators:'' [[Aniracetam]]
 +
* [[BIIB-104|BIIB-104 (PF-04958242)]]
 
* [[Cyclothiazide]]
 
* [[Cyclothiazide]]
 
* [[CX-516]]
 
* [[CX-516]]
Line 39: Line 40:
 
* [[Oxiracetam]]
 
* [[Oxiracetam]]
 
* [[PEPA (drug)|PEPA]]
 
* [[PEPA (drug)|PEPA]]
* [[PF-04958242]]
 
 
* [[Piracetam]]
 
* [[Piracetam]]
 
* [[Pramiracetam]]
 
* [[Pramiracetam]]
Line 68: Line 68:
 
* [[Cyclopropane]]
 
* [[Cyclopropane]]
 
* [[Enflurane]]
 
* [[Enflurane]]
* [[Ethanol]]
+
* [[Alcohol (drug)|Ethanol (alcohol)]]
 
* [[Evans blue]]
 
* [[Evans blue]]
 
* [[GYKI-52466]]
 
* [[GYKI-52466]]
Line 78: Line 78:
 
* [[Pregnenolone sulfate]]
 
* [[Pregnenolone sulfate]]
 
* [[Sevoflurane]]
 
* [[Sevoflurane]]
* [[Talampanel]]
+
* [[Talampanel]]; ''Unknown/unsorted antagonists:'' [[Minocycline]]
  
 
  | group2 = {{abbrlink|KAR|Kainate receptor}}
 
  | group2 = {{abbrlink|KAR|Kainate receptor}}
Line 117: Line 117:
 
* [[UBP-302]]; ''Negative allosteric modulators:'' [[Barbiturates]] (e.g., [[pentobarbital]], [[sodium thiopental]])
 
* [[UBP-302]]; ''Negative allosteric modulators:'' [[Barbiturates]] (e.g., [[pentobarbital]], [[sodium thiopental]])
 
* [[Enflurane]]
 
* [[Enflurane]]
* [[Ethanol]]
+
* [[Alcohol (drug)|Ethanol (alcohol)]]
 
* [[Evans blue]]
 
* [[Evans blue]]
 
* [[NS-3763]]
 
* [[NS-3763]]
Line 155: Line 155:
 
* [[Neboglamine|Neboglamine (nebostinel)]]
 
* [[Neboglamine|Neboglamine (nebostinel)]]
 
* [[Rapastinel|Rapastinel (GLYX-13)]]
 
* [[Rapastinel|Rapastinel (GLYX-13)]]
* [[Sarcosine]]; ''Polyamine site agonists:'' [[Spermidine]]
+
* [[Sarcosine]]; ''Polyamine site agonists:'' [[Neomycin]]
 +
* [[Spermidine]]
 
* [[Spermine]]; ''Other positive allosteric modulators:'' [[24S-Hydroxycholesterol|24''S''-Hydroxycholesterol]]
 
* [[Spermine]]; ''Other positive allosteric modulators:'' [[24S-Hydroxycholesterol|24''S''-Hydroxycholesterol]]
 
* {{abbrlink|DHEA|Dehydroepiandrosterone}} ([[prasterone]])
 
* {{abbrlink|DHEA|Dehydroepiandrosterone}} ([[prasterone]])
Line 161: Line 162:
 
* [[Epipregnanolone sulfate]]
 
* [[Epipregnanolone sulfate]]
 
* [[Pregnenolone sulfate]]
 
* [[Pregnenolone sulfate]]
 +
* [[SAGE-201]]
 +
* [[SAGE-301]]
 
* [[SAGE-718]]
 
* [[SAGE-718]]
  
Line 184: Line 187:
 
* [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]
 
* [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]
 
* [[SDZ-220581]]
 
* [[SDZ-220581]]
* [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15896]]
+
* [[Selfotel]]; ''Glycine site antagonists:'' [[4-Chlorokynurenine|4-Cl-KYN (AV-101)]]
* [[Caroverine]]
+
* [[5,7-Dichlorokynurenic acid|5,7-DCKA]]
* [[Dexanabinol]]
+
* [[7-Chlorokynurenate|7-CKA]]
* [[FPL-12495]]
+
* [[1-Aminocyclopropane-1-carboxylic acid|ACC]]
* [[FR-115427]]
+
* [[ACEA-1011]]
* [[Hodgkinsine]]
+
* [[ACEA-1328]]
* [[Magnesium]]
+
* [[Apimostinel|Apimostinel (NRX-1074)]]
* [[MDL-27266]]
+
* [[AV-101]]
* [[Psychotridine]]
+
* [[Carisoprodol]]
* [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]
+
* [[CGP-39653]]
 +
* [[CNQX]]
 +
* [[Cycloserine|<small>D</small>-Cycloserine]]
 +
* [[DNQX]]
 +
* [[Felbamate]]
 +
* [[Gavestinel]]
 +
* [[GV-196771]]
 +
* [[Harkoseride]]
 +
* [[Kynurenic acid]]
 +
* [[Kynurenine]]<!--As a prodrug of kynurenic acid-->
 +
* [[L-689560]]
 +
* [[L-701324]]
 +
* [[Licostinel|Licostinel (ACEA-1021)]]
 +
* [[LU-73068]]
 +
* [[MDL-105519]]
 +
* [[Meprobamate]]
 +
* [[MRZ 2/576]]
 +
* [[PNQX]]
 +
* [[Rapastinel|Rapastinel (GLYX-13)]]
 +
* [[ZD-9379]]; ''Polyamine site antagonists:'' [[Arcaine]]
 +
* [[Co 101676]]
 +
* [[1,3-Diaminopropane|Diaminopropane]]
 +
* [[Diethylenetriamine]]
 +
* [[Huperzine A]]
 +
* [[Putrescine]]; ''Uncompetitive pore blockers (mostly dizocilpine site):'' [[2-MDP]]
 
* [[3-HO-PCP]]
 
* [[3-HO-PCP]]
 
* [[3-MeO-PCE]]
 
* [[3-MeO-PCE]]
Line 203: Line 230:
 
* [[Alpha-Endopsychosin|α-Endopsychosin]]
 
* [[Alpha-Endopsychosin|α-Endopsychosin]]
 
* [[Alaproclate]]
 
* [[Alaproclate]]
 +
* [[Alazocine|Alazocine (SKF-10047)]]
 
* [[Amantadine]]
 
* [[Amantadine]]
 
* [[Aptiganel]]
 
* [[Aptiganel]]
Line 215: Line 243:
 
* [[Dexoxadrol]]
 
* [[Dexoxadrol]]
 
* [[Dextrallorphan]]
 
* [[Dextrallorphan]]
 +
* [[Dextromethadone]]
 +
* [[Dextromethorphan]]
 +
* [[Dextrorphan]]
 
* [[Dieticyclidine]]
 
* [[Dieticyclidine]]
 
* [[Diphenidine]]
 
* [[Diphenidine]]
Line 230: Line 261:
 
* [[Ketobemidone]]
 
* [[Ketobemidone]]
 
* [[Lanicemine]]
 
* [[Lanicemine]]
 +
* [[Levomethadone]]
 +
* [[Levomethorphan]]
 +
* [[Levomilnacipran]]
 +
* [[Levorphanol]]
 
* [[Loperamide]]
 
* [[Loperamide]]
 
* [[Memantine]]
 
* [[Memantine]]
* [[Methadone]] ([[Levomethadone]])
+
* [[Methadone]]
* [[Methorphan]] ([[Dextromethorphan]]
+
* [[Methorphan]]
* [[Levomethorphan]])
 
 
* [[Methoxetamine]]
 
* [[Methoxetamine]]
 
* [[Methoxphenidine]]
 
* [[Methoxphenidine]]
 
* [[Milnacipran]]
 
* [[Milnacipran]]
* [[Morphanol]] ([[Dextrorphan]]
+
* [[Morphanol]]
* [[Levorphanol]])
 
 
* [[NEFA (drug)|NEFA]]
 
* [[NEFA (drug)|NEFA]]
* [[Nefopam]]
 
 
* [[Neramexane]]
 
* [[Neramexane]]
 
* [[Nitromemantine]]
 
* [[Nitromemantine]]
* [[Nitrous oxide]]
 
 
* [[Noribogaine]]
 
* [[Noribogaine]]
 
* [[Norketamine]]
 
* [[Norketamine]]
Line 262: Line 293:
 
* [[Tenocyclidine]]
 
* [[Tenocyclidine]]
 
* [[Tiletamine]]
 
* [[Tiletamine]]
* [[Tramadol]]
+
* [[Tramadol]]; ''Ifenprodil (NR2B) site antagonists:''
* [[Xenon]]; ''Glycine site antagonists:'' [[4-Chlorokynurenine|4-Cl-KYN (AV-101)]]
 
* [[5,7-Dichlorokynurenic acid|5,7-DCKA]]
 
* [[7-Chlorokynurenate|7-CKA]]
 
* [[1-Aminocyclopropane-1-carboxylic acid|ACC]]
 
* [[ACEA-1011]]
 
* [[ACEA-1328]]
 
* [[AV-101]]
 
* [[Carisoprodol]]
 
* [[CGP-39653]]
 
* [[CNQX]]
 
* [[DNQX]]
 
* [[Felbamate]]
 
* [[Gavestinel]]
 
* [[GV-196771]]
 
* [[Kynurenic acid]]
 
* [[Kynurenine]]<!--As a prodrug of kynurenic acid-->
 
* [[L-689560]]
 
* [[L-701324]]
 
* [[Licostinel|Licostinel (ACEA-1021)]]
 
* [[LU-73068]]
 
* [[MDL-105519]]
 
* [[Meprobamate]]
 
* [[MRZ 2/576]]
 
* [[PNQX]]
 
* [[ZD-9379]]; ''Ifenprodil (NR2B) site antagonists:''
 
 
* [[Besonprodil]]
 
* [[Besonprodil]]
* [[Eliprodil]]
+
* [[Buphenine|Buphenine (nylidrin)]]
* [[Haloperidol]]
 
* [[Radiprodil]]
 
* [[Ro 25-6981]]
 
* [[Safaprodil]]
 
* [[Traxoprodil]]
 
 
 
 
 
''NR2B subunit antagonists:''
 
 
* [[CO-101244|CO-101244 (PD-174494)]]
 
* [[CO-101244|CO-101244 (PD-174494)]]
 
* [[Eliprodil]]
 
* [[Eliprodil]]
 
* [[Haloperidol]]
 
* [[Haloperidol]]
* [[Ifenprodil]]
 
 
* [[Isoxsuprine]]
 
* [[Isoxsuprine]]
* [[Nylidrin]]
+
* [[Radiprodil|Radiprodil (RGH-896)]]
 
* [[Rislenemdaz|Rislenemdaz (CERC-301, MK-0657)]]
 
* [[Rislenemdaz|Rislenemdaz (CERC-301, MK-0657)]]
* [[Ro8-4304]]
+
* [[Ro 8-4304]]
* [[Ro25-6981]]
+
* [[Ro 25-6981]]
* [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]
+
* [[Safaprodil]]
* [[Co 101676]]
+
* [[Traxoprodil|Traxoprodil (CP-101606)]]; ''NR2A-selective antagonists:'' [[MPX-004]]
* [[1,3-Diaminopropane|Diaminopropane]]
+
* [[MPX-007]]
* [[Diethylenetriamine]]
+
* [[TCN-201]]
* [[Huperzine A]]
+
* [[TCN-213]]; ''Cations:'' [[Hydrogen]]
* [[Putrescine]]
+
* [[Magnesium]]
* [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Bumetanide]]
+
* [[Zinc]]; ''Alcohols/volatile anesthetics/related:'' [[Benzene]]
 +
* [[Butane]]
 
* [[Chloroform]]
 
* [[Chloroform]]
 
* [[Cyclopropane]]
 
* [[Cyclopropane]]
* [[D-α-Aminoadipate|<small>D</small>-αAA]]
+
* [[Desflurane]]
 
* [[Diethyl ether]]
 
* [[Diethyl ether]]
 
* [[Enflurane]]
 
* [[Enflurane]]
* [[Ethanol]]
+
* [[Alcohol (drug)|Ethanol (alcohol)]]
 +
* [[Halothane]]
 +
* [[Hexanol]]
 +
* [[Isoflurane]]
 +
* [[Methoxyflurane]]
 +
* [[Nitrous oxide]]
 +
* [[Octanol]]
 +
* [[Sevoflurane]]
 +
* [[Toluene]]
 +
* [[1,1,1-Trichloroethane|Trichloroethane]]
 +
* [[2,2,2-Trichloroethanol|Trichloroethanol]]
 +
* [[Trichloroethylene]]
 +
* [[Ethyl carbamate|Urethane]]
 +
* [[Xenon]]
 +
* [[Xylene]]; ''Unknown/unsorted antagonists:'' [[ARR-15896]]
 +
* [[Bumetanide]]
 +
* [[Caroverine]]
 +
* [[Conantokin]]
 +
* [[D-α-Aminoadipate|<small>D</small>-αAA]]
 +
* [[Dexanabinol]]
 
* [[Flufenamic acid]]
 
* [[Flufenamic acid]]
 
* [[Flupirtine]]
 
* [[Flupirtine]]
 +
* [[FPL-12495]]
 +
* [[FR-115427]]
 
* [[Furosemide]]
 
* [[Furosemide]]
* [[Halothane]]
+
* [[Hodgkinsine]]
 
* [[Ipenoxazone|Ipenoxazone (MLV-6976)]]
 
* [[Ipenoxazone|Ipenoxazone (MLV-6976)]]
* [[Isoflurane]]
+
* [[MDL-27266]]
 
* [[Metaphit]]<!--Irreversible-->
 
* [[Metaphit]]<!--Irreversible-->
* [[Methoxyflurane]]
+
* [[Minocycline]]
 +
* [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]
 
* [[Niflumic acid]]
 
* [[Niflumic acid]]
 +
* [[Pentamidine]]
 
* [[Pentamidine isethionate]]
 
* [[Pentamidine isethionate]]
 
* [[Piretanide]]
 
* [[Piretanide]]
* [[Toluene]]
+
* [[Psychotridine]]
 
* [[Transcrocetin]] ([[saffron]])
 
* [[Transcrocetin]] ([[saffron]])
* [[1,1,1-Trichloroethane|Trichloroethane]]
 
* [[2,2,2-Trichloroethanol|Trichloroethanol]]
 
* [[Trichloroethylene]]
 
* [[Xylene]]
 
  
| below = '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]] • [[Template:Metabotropic glutamate receptor modulators|Metabotropic glutamate receptor modulators]] • [[Template:Glutamate metabolism and transport modulators|Glutamate metabolism/transport modulators]]''
+
* '''Unsorted:''' ''Allosteric modulators:'' [[AGN-241751]]
  
}}<noinclude>
+
|below =
{{collapsible option}}
+
* '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]''
 +
* ''[[Template:Metabotropic glutamate receptor modulators|Metabotropic glutamate receptor modulators]]''
 +
* ''[[Template:Glutamate metabolism and transport modulators|Glutamate metabolism/transport modulators]]''
 +
}}
 +
<noinclude>
 +
{{Collapsible option}}
 
[[Category:Drug templates by receptor, channel, or pump]]
 
[[Category:Drug templates by receptor, channel, or pump]]
 
</noinclude>
 
</noinclude>

Latest revision as of 17:35, 1 August 2018

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Ionotropic glutamate receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Ionotropic glutamate receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Ionotropic glutamate receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.